{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:41:57Z","timestamp":1792226517227,"version":"4.4.0"},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T00:00:00Z","timestamp":1177372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Since the introduction of highly active antiretroviral therapy (HAART), the incidence of death in HIV\u2010infected patients has dramatically decreased, and causes of death other than those related to HIV infection have increased, although it is unclear how these parameters compare with those in the age\u2010matched general population living in the same geographical region.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Consecutive HIV\u2010infected adults who were prescribed HAART in our hospital were prospectively followed from January 1997 to December 2004 or until death, loss to follow\u2010up or discontinuation of HAART. Estimations of the annual incidence and causes of death in the general population of similar age in Catalonia per calendar year in the study period were obtained and compared with those in the HIV\u2010infected cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 235 deaths among the 4471 patients on HAART (5%). The incidence of mortality decreased over time in HIV\u2010infected patients (<jats:italic>P<\/jats:italic>&lt;0.001; \u03c7<jats:sup>2<\/jats:sup> test for trend), although it has remained approximately five times higher than that for the age\u2010matched general population. AIDS\u2010related events were the most common cause of death (<jats:italic>n<\/jats:italic>=95; 40%), although they significantly decreased over time (<jats:italic>P<\/jats:italic>&lt;0.001; \u03c7<jats:sup>2<\/jats:sup> test for trend), whereas liver diseases (<jats:italic>P<\/jats:italic>&lt;0.001; \u03c7<jats:sup>2<\/jats:sup> test for trend) and non\u2010AIDS\u2010defining infections (<jats:italic>P=<\/jats:italic>0.008; \u03c7<jats:sup>2<\/jats:sup> test for trend) significantly increased over time. Infections in general (33 times higher), liver diseases (11 times higher) and non\u2010Hodgkin lymphoma (5 times higher) were overrepresented as causes of death in the HIV\u2010infected cohort compared with the age\u2010matched general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Non\u2010AIDS\u2010defining infectious diseases, liver diseases, and non\u2010Hodgkin lymphoma represent specific targets for efforts to further decrease mortality in HIV\u2010infected patients receiving HAART.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2007.00468.x","type":"journal-article","created":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T17:21:01Z","timestamp":1177435261000},"page":"251-258","source":"Crossref","is-referenced-by-count":93,"title":["Incidence and causes of death in HIV\u2010infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area"],"prefix":"10.1111","volume":"8","author":[{"given":"E","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Milinkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Buira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"De Lazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Larrousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lonc\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Laguno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mallolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Gatell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1194","article-title":"Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland","volume":"315","author":"Egger M","year":"1997","journal-title":"prospective multicentre study. Swiss Cohort Study"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03201-2"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-1-200107030-00005"},{"key":"e_1_2_6_6_2","first-page":"863","article-title":"Clinical progression and virological failure on highly active antiretroviral therapy in HIV\u20101 patients","volume":"353","author":"Ledergerber B","year":"1999","journal-title":"a prospective cohort study"},{"key":"e_1_2_6_7_2","first-page":"378","article-title":"Long\u2010term effectiveness of potent antiretroviral therapy in preventing AIDS and death","volume":"366","author":"Sterne JAC","year":"2005","journal-title":"a prospective cohort study"},{"key":"e_1_2_6_8_2","first-page":"2009","article-title":"Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy","volume":"19","author":"Schneider MF","year":"2005","journal-title":"1984\u20132004"},{"key":"e_1_2_6_9_2","unstructured":"WeberR Friis\u2010M\u00f8llerN SabinCet alHIV and non\u2010HIV\u2010related deaths and their relationship to immunodeficiency: The D.A.D. Study.XIIth Conference on Retroviruses and Opportunistic Infections. Boston MA February 2005 [Abstract 595]."},{"key":"e_1_2_6_10_2","unstructured":"El\u2010SadrW NeatonJ.Episodic CD4\u2010guided use of ART is inferior to continuous therapy: results of the SMART Study.XIIIth Conference on Retroviruses and Opportunistic Infections. Denver CO February 2006 [Abstract 106LB]."},{"key":"e_1_2_6_11_2","first-page":"119","article-title":"Prognosis of HIV\u20101\u2010infected patients starting highly active antiretroviral therapy","volume":"360","author":"Egger M","year":"2002","journal-title":"a collaborative analysis of prospective studies"},{"key":"e_1_2_6_12_2","first-page":"1663","article-title":"Changes in the cause of death among HIV positive subjects across Europe","volume":"16","author":"Mocroft A","year":"2002","journal-title":"results from the EuroSIDA study"},{"key":"e_1_2_6_13_2","first-page":"2333","article-title":"Causes of death in HIV infection","volume":"18","author":"Mocroft A","year":"2004","journal-title":"the key determinant to define the clinical response to anti-HIV therapy"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000194799.43799.ea"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/343862"},{"key":"e_1_2_6_16_2","first-page":"1046","article-title":"Mortality in HIV\u2010seropositive versus \u2010seronegative persons in the era of highly active antiretroviral therapy","volume":"190","author":"Wang C","year":"2004","journal-title":"implications for when to initiate therapy"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00271.x"},{"key":"e_1_2_6_18_2","first-page":"121","article-title":"Causes of death among human immunodeficiency virus (HIV)\u2010infected adults in the era of potent antiretroviral therapy","volume":"34","author":"Lewden C","year":"2005","journal-title":"emerging role of hepatitis and cancers, persistent role of AIDS"},{"key":"e_1_2_6_19_2","first-page":"194","article-title":"Comparisons of causes of death and mortality rates among HIV\u2010infected persons","volume":"41","author":"Crum NF","year":"2006","journal-title":"analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras"},{"key":"e_1_2_6_20_2","unstructured":"P\u00e9rez\u2010CuevasB.Influencia del Tratamiento Antirretrov\u00edrico de Gran Actividad en la Incidencia de las Infecciones Oportunistas y Neoplasias Asociadas a la Infecci\u00f3n por VIH\u20101 y en la Mortalidad.http:\/\/www.tdx.cesca.es\/TESIS_UB\/AVAILABLE\/TDX\u20100213102\u2010091238\/TOL33.pdf2006."},{"key":"e_1_2_6_21_2","first-page":"592","article-title":"Risk of lipodystrophy in HIV\u20101\u2010infected patients treated with protease inhibitors","volume":"357","author":"Martinez E","year":"2001","journal-title":"a prospective cohort study"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200406010-00007"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199814000-00013"},{"key":"e_1_2_6_24_2","unstructured":"Iustitut d'Estad\u00edstica de Catalunya. Estudis de la poblaci\u00f3.http:\/\/www.idescat.net\/cat\/poblacio\/poblestudis.html2007."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000165911.97085.d0"},{"key":"e_1_2_6_26_2","first-page":"289","article-title":"Survival and progression to AIDS in a seroconverter cohort in the post\u2010highly active antiretroviral therapy era","volume":"20","author":"P\u00e9rez\u2010Hoyos S","year":"2006","journal-title":"effectiveness goes on"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000189858.59559.d2"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000206508.32030.92"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14307-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200409030-00013"},{"key":"e_1_2_6_31_2","unstructured":"RockstrohJ KonopnickiD MocroftAet al. Hepatitis B. and hepatitis C in the EuroSIDA cohort: prevalence and effect on mortality AIDS progression and response to HAART.XIth Conference on Retroviruses and Opportunistic Infections. San Francisco CA February 2004 [Abstract 799]."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3406"},{"key":"e_1_2_6_33_2","first-page":"478","article-title":"Systemic non\u2010Hodgkin lymphoma in HIV\u2010infected patients with effective suppression of HIV replication","volume":"30","author":"Gerard L","year":"2002","journal-title":"persistent occurrence but improved survival"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2007.00468.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2007.00468.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:13:09Z","timestamp":1696903989000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2007.00468.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,24]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1468-1293.2007.00468.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2007.00468.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,24]]}}}